Amneal Pharmaceuticals (AMRX) Inventory Average (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Inventory Average of $624.0 million for Q1 2026, up 2.8% year-over-year from $606.9 million in Q1 2025, and up 2.22% quarter-over-quarter from $610.4 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Inventory Average (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $624.0 million for Q1 2026.
- In Q1 2026, Inventory Average rose 2.8% year-over-year to $624.0 million; the TTM figure through Mar 2026 stood at $624.0 million (up 2.8% YoY), while the FY2025 annual figure was $609.4 million, up 2.09% from the prior year.
- Inventory Average for Q1 2026 stood at $624.0 million, up from $610.4 million in the prior quarter.
- The five-year high for Inventory Average was $624.0 million in Q1 2026, with the low at $500.8 million in Q1 2022.
- The 5-year median for Inventory Average is $576.0 million (2024), against an average of $571.1 million.
- The sharpest annual moves came in 2024 and 2025: Inventory Average advanced 8.71% in 2024, then increased 0.99% in 2025.
- Amneal Pharmaceuticals' Inventory Average stood at $537.3 million in 2022, then grew by 7.75% to $578.9 million in 2023, then grew by 4.4% to $604.4 million in 2024, then gained by 0.99% to $610.4 million in 2025, then rose by 2.22% to $624.0 million in 2026.
- Business Quant data shows AMRX's Inventory Average at $624.0 million in Q1 2026, $610.4 million in Q4 2025, and $611.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 659.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 659.79 Mn |
| Mar 31, 2026 | 623.96 Mn |
| Dec 31, 2025 | 610.40 Mn |
| Sep 30, 2025 | 611.74 Mn |
| Jun 30, 2025 | 605.20 Mn |
| Mar 31, 2025 | 606.94 Mn |
| Dec 31, 2024 | 604.41 Mn |
| Sep 30, 2024 | 585.99 Mn |
| Jun 30, 2024 | 573.14 Mn |
| Mar 31, 2024 | 576.02 Mn |
| Dec 31, 2023 | 578.93 Mn |
| Sep 30, 2023 | 563.52 Mn |
| Jun 30, 2023 | 539.80 Mn |
| Mar 31, 2023 | 529.89 Mn |
| Dec 31, 2022 | 537.30 Mn |
| Sep 30, 2022 | 538.44 Mn |
| Jun 30, 2022 | 522.63 Mn |
| Mar 31, 2022 | 500.82 Mn |
| Dec 31, 2021 | 504.82 Mn |
| Sep 30, 2021 | 521.82 Mn |